Cardiophrenic lymph nodes in advanced ovarian cancer

被引:3
|
作者
Agusti, Nuria [1 ]
Bonaldo, Giulio [2 ]
Kahn, Ryan M. [3 ]
Rosati, Andrea [4 ]
Nachira, Dania [5 ]
Pan, Teresa L. [6 ]
Mburu, Anisa [7 ]
Kochiashvili, Gvantsa [8 ,9 ]
Paredes, Pilar [10 ]
Hsu, Heng-Cheng [11 ]
Davies-Oliveira, Jennifer [12 ]
Ramirez, Pedro T. [13 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Padua, Dept Women & Childrens Hlth, Clin Gynecol & Obstet, Padua, Italy
[3] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dipartimento Salute Donna & Bambino & San Pubbl, IRCCS, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dept Gen Thorac Surg, IRCCS, Rome, Italy
[6] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
[7] Aga Khan Hosp Mombasa, Dept Gynecol & Obstet, Mombasa, Kenya
[8] Caucasus Med Ctr, Dept Gynecol Oncol, Tbilisi, Georgia
[9] David Tvildiani Med Univ, Dept Surg, Tbilisi, Georgia
[10] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[11] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Hsin Chu Branch, Hsinchu, Taiwan
[12] Univ Manchester, Div Canc Sci, Manchester, England
[13] Houston Methodist Hosp, Dept Obstet & Gynecol, Houston, TX USA
关键词
Ovarian Neoplasms; Surgical Oncology; Lymphatic Metastasis; ASSISTED THORACIC-SURGERY; CYTOREDUCTIVE SURGERY; THORACOSCOPIC SURGERY; RESECTION; CARCINOMA; FEASIBILITY; METASTASIS; DISSECTION; MANAGEMENT; MODERATE;
D O I
10.1136/ijgc-2023-004963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer most commonly presents at advanced stages, and prognosis is influenced by residual disease following cytoreduction. The significance of cardiophrenic lymph node resection at the time of cytoreductive surgery in advanced ovarian cancer remains a topic of debate. Enlarged cardiophrenic lymph nodes are detected through high-resolution imaging; however, the optimal imaging technique in determining feasibility of node resection remains uncertain. Similarly, the impact of excision of cardiophrenic lymph nodes on progression-free and overall survival remains elusive. The indications for resection of cardiophrenic lymph nodes are not addressed in standard ovarian cancer guidelines. Patients with cardiophrenic lymph nodes exceeding 1 cm in size may be considered for resection if complete intra-abdominal cytoreduction is feasible to no gross residual. The surgical approach might be either by open access or by video-assisted thoracoscopic surgery (minimally invasive approach), and major complications following cardiophrenic lymph nodes resection are low. Pathological cardiophrenic lymph nodes are associated with a poorer overall prognosis and can serve as a prognostic parameter; however, the therapeutic benefit of cardiophrenic lymph nodes resection remains inconclusive.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [21] Transdiaphragmatic cardiophrenic lymph node resection in a patient with an advanced-stage ovarian cancer
    Turkmen, Osman
    Kilic, Fatih
    Ersak, Burak
    Comert, Gunsu Kimyon
    Ayhan, Sevgi
    Ozdemir, Mustafa
    Turan, Taner
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (03) : 527 - 529
  • [22] Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer
    Cowan, Renee A.
    Tseng, Jill
    Murthy, Vijayashree
    Srivastava, Radhika
    Roche, Kara C. Long
    Zivanovic, Oliver
    Gardner, Ginger J.
    Chi, Dennis S.
    Park, Bernard J.
    Sonoda, Yukio
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 147 (02) : 262 - 266
  • [23] Left cardiophrenic lymph node resection for advanced ovarian cancer with adhesion to the thoracic cavity
    Matsuoka, Ayumu
    Tate, Shinichi
    Nishikimi, Kyoko
    Shozu, Makio
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 151 (02) : 390 - 391
  • [24] Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer
    Plana, Alba
    Talo, Robert
    Wallengren, Nils-Olof
    Pudaric, Sonja
    Sartor, Hanna
    Asp, Mihaela
    [J]. ACTA ONCOLOGICA, 2023, 62 (05) : 451 - 457
  • [25] Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer
    Luengas-Wuerzinger, Veronica
    Rawert, Friederike
    Spee, Sabrina Classen-Von
    Baransi, Saher
    Schuler, Esther
    Carrizo, Katharina
    Mallmann, Peter
    Lampe, Bjoern
    [J]. ANTICANCER RESEARCH, 2021, 41 (10) : 5025 - 5031
  • [26] Thoracic anatomical landmarks and uniportal VATS cardiophrenic lymph node resection in advanced ovarian cancer
    Boria, Felix
    Rodriguez-Perez, Maria
    Vazquez-Vicente, Daniel
    Castellanos, Teresa
    Chacon, Enrique
    Chiva, Luis
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (05) : 793 - 794
  • [27] Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography
    Kim, Tae-Hyung
    Lim, Myong Cheol
    Kim, Se Ik
    Seo, Sang-Soo
    Kim, Sun Ho
    Park, Sang-Yoon
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1302 - 1308
  • [28] Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography
    Tae-Hyung Kim
    Myong Cheol Lim
    Se Ik Kim
    Sang-Soo Seo
    Sun Ho Kim
    Sang-Yoon Park
    [J]. Annals of Surgical Oncology, 2016, 23 : 1302 - 1308
  • [29] Transdiaphragmatic and transxiphoid cardiophrenic lymph node resection step-by-step in advanced ovarian cancer
    Martinez-Gomez, Carlos
    Angeles, Martina Aida
    Leray, Helene
    Tanguy Le Gac, Yann
    Ferron, Gwenael
    Martinez, Alejandra
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (10) : 1646 - 1647
  • [30] Transdiaphragmatic resection of enlarged cardiophrenic lymph node during interval debulking surgery for advanced ovarian cancer
    Addley, Susan
    Morotti, Matteo
    Pinelli, Ciro
    Majd, Hooman Soleymani
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37